Heparin Anticoagulation in Septic Shock

PHASE2TerminatedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

March 12, 2018

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Septic ShockVasodilatory Shock
Interventions
DRUG

Unfractionated heparin

UFH initiated at 18 IU/kg/hr, dosed according to total body weight and pragmatically adjusted according to local institutional policy to achieve an activated partial thromboplastin (aPTT) of 1.5 to 2.5 times that of the reference aPTT value or anti-Xa values targeted to local practice levels. Duration of study intervention will be a maximum of 5 days (120 hours) or until vasopressors have been discontinued for 24 continuous hours. All participants will then receive venous thromboprophylaxis according to local practice.

OTHER

Venous thromboprophylaxis (VTE)

May include subcutaneous heparin or dalteparin, sequential compression device or graduated compression stockings

Trial Locations (51)

53226

Froedtert Hospital, Milwaukee

Unknown

Hospital Sao Jose, Altamira

Hospital Novo Atibaia, Atibaia

Hospital de Amor (Barretos), Barretos

Santa Casa de Misericórdia de Belo Horizonte, Belo Horizonte

Hospital Tacchini, Bento Gonçalves

Hospital de Brasília, Brasília

Hospital Ortopedico e Medicina Especializada ltda. - HOME, Brasília

Instituto de Cardiologia do Distrito Federal, Brasília

Hospital Maternidade São José, Colatina

Hospital Baía Sul, Florianópolis

Hospital Nereu Ramos, Florianópolis

Hospital de Amor Jales, Jales

Unimed Cariri Hospital, Juazeiro do Norte

Hospital de Clínicas de Porto Alegre, Porto Alegre

Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre

Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto, Ribeirão Preto

Hospital Bruno Born, Rio Grande

Hospital da Cidade, Salvador

Santa Casa de São João Del Rei, São João del Rei

Hospital AC Camargo, São Paulo

Hospital Beneficência Portuguesa, São Paulo

Hospital da Luz, São Paulo

Hospital das Clinicas da faculdade de Medicina de Universidade de São Paulo, São Paulo

Hospital e Maternidade Sao Vicente, São Paulo

Hospital Santa Paula, São Paulo

Hospital Sepaco, São Paulo

Instituto de Assistência Médica ao Servidor Público Estadual de São Paulo, São Paulo

Universidade Federal de Sao Paulo - UNIFESP, São Paulo

Hospital Ana Nery, Taguatinga

ATTIKON University Hospital, Athens

Korgialeneion Benakeion Hospital, Athens

AMRI Hospital Kolkata, Kolkata

Dr Ruth K.M. PFAU Civil Hospital, Karachi

Shaheed Mohtarma Benazir Bhutto Trauma Center, Karachi

The Indus Hospital, Karachi

Mayo Hospital Lahore, Lahore

The Asian Hospital, Manila

The Medical City, Manila

The Philippines General Hospital, Manila

T2N 2T9

Foothills Medical Centre, Calgary

V8R 1J8

Vancouver Island Health Authority, Victoria

R2H 2A6

St Boniface General Hospital, Winnipeg

R3A 1R9

Health Sciences Centre Winnipeg, Winnipeg

K1H 8L6

The Ottawa Hospital - General Campus, Ottawa

K1Y 4E9

The Ottawa Hospital - Civic Campus, Ottawa

L2S 0A9

Niagara Health System - St Catharines Site, Saint Catherines

M5B 1W8

St Michael's Hospital, Toronto

H2X 0A9

Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal

G1V 4G5

Institut Universitaire de Cardiologie et de Pneumologie de Quebec - Universite Laval, Québec

G1J 1Z4

Hopital de l'Enfant-Jesus, Québec

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

CancerCare Manitoba

OTHER

lead

University of Manitoba

OTHER

NCT03378466 - Heparin Anticoagulation in Septic Shock | Biotech Hunter | Biotech Hunter